Patient clinical and laboratory features
| . | Patient 1 . | Patient 2 . |
|---|---|---|
| Age | 65 | 59 |
| Karyotype | 46, XY (20/20) | 46, XY (20/20) |
| Hemoglobin (g/dL) | ND | 10.7 |
| White cell count (/L) | 15 × 109 | 20 × 106 |
| Platelet count (/L) | 400 × 109 | 527 × 109 |
| Bone marrow | ND | Dysplastic features |
| NAP score | 70 | 39 |
| Splenomegaly | No | No |
| . | Patient 1 . | Patient 2 . |
|---|---|---|
| Age | 65 | 59 |
| Karyotype | 46, XY (20/20) | 46, XY (20/20) |
| Hemoglobin (g/dL) | ND | 10.7 |
| White cell count (/L) | 15 × 109 | 20 × 106 |
| Platelet count (/L) | 400 × 109 | 527 × 109 |
| Bone marrow | ND | Dysplastic features |
| NAP score | 70 | 39 |
| Splenomegaly | No | No |
ND indicates not determined; NAP, neutrophil alkaline phosphatase.